One dose of COVID-19 nanoparticle vaccine REVC-128 protects against SARS-CoV-2 challenge at two weeks post-immunization
Maggie Gu, Jonathan L Torres, Yijia Li, Alex Van Ry, Jack Greenhouse, Shannon Wallace, Chi-I Chiang, Laurent Pessaint, Abigail M Jackson, Maciel Porto, others
January, 2021